Northwestern Mutual Wealth Management Co. lifted its stake in Express Scripts Holding Co (NASDAQ:ESRX) by 92.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 72,632 shares of the company’s stock after purchasing an additional 34,973 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Express Scripts were worth $6,885,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in the stock. Bank of Stockton raised its position in Express Scripts by 5.2% during the 3rd quarter. Bank of Stockton now owns 11,821 shares of the company’s stock worth $1,123,000 after buying an additional 581 shares during the last quarter. Busey Trust CO increased its holdings in shares of Express Scripts by 0.5% during the 3rd quarter. Busey Trust CO now owns 114,461 shares of the company’s stock valued at $10,874,000 after purchasing an additional 617 shares in the last quarter. Strategic Advisors LLC increased its holdings in shares of Express Scripts by 11.2% during the 3rd quarter. Strategic Advisors LLC now owns 6,201 shares of the company’s stock valued at $589,000 after purchasing an additional 623 shares in the last quarter. Sumitomo Life Insurance Co. increased its holdings in shares of Express Scripts by 4.5% during the 2nd quarter. Sumitomo Life Insurance Co. now owns 15,313 shares of the company’s stock valued at $1,182,000 after purchasing an additional 657 shares in the last quarter. Finally, Gibraltar Capital Management Inc. increased its holdings in shares of Express Scripts by 1.1% during the 2nd quarter. Gibraltar Capital Management Inc. now owns 68,278 shares of the company’s stock valued at $5,272,000 after purchasing an additional 750 shares in the last quarter. 84.20% of the stock is owned by hedge funds and other institutional investors.
In related news, insider Christine Houston sold 12,898 shares of Express Scripts stock in a transaction on Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the sale, the insider now owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.79% of the stock is currently owned by company insiders.
Express Scripts stock opened at $98.19 on Wednesday. Express Scripts Holding Co has a 1 year low of $59.17 and a 1 year high of $98.98. The firm has a market capitalization of $54.55 billion, a P/E ratio of 13.83, a P/E/G ratio of 1.22 and a beta of 0.89. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.65 and a current ratio of 0.77.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.01. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The firm had revenue of $25.56 billion for the quarter, compared to analysts’ expectations of $25.11 billion. During the same quarter last year, the company earned $2.51 EPS. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. As a group, analysts forecast that Express Scripts Holding Co will post 9.08 EPS for the current year.
Several equities analysts have recently weighed in on ESRX shares. Royal Bank of Canada set a $101.00 target price on shares of Express Scripts and gave the company a “buy” rating in a report on Thursday, November 1st. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Tuesday, September 18th. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, September 17th. Cowen reaffirmed a “buy” rating and set a $88.00 target price on shares of Express Scripts in a report on Friday, November 2nd. Finally, Barclays lifted their target price on shares of Express Scripts from $83.00 to $90.00 and gave the company an “equal weight” rating in a report on Thursday, November 1st. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Express Scripts has a consensus rating of “Hold” and an average price target of $89.07.
COPYRIGHT VIOLATION WARNING: This story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.dispatchtribunal.com/2018/11/07/express-scripts-holding-co-esrx-shares-bought-by-northwestern-mutual-wealth-management-co.html.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Read More: What is dollar cost averaging (DCA)?
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.